NASDAQ$SEER
Seer Inc · Q2 2023 earnings
Q2 2023 earnings · · Investor relations
Briefing
Reported an 11% increase in revenue compared to the prior year period and launched the Proteograph XT Assay Kit.
Seer, Inc. reported revenue of $4.0 million for Q2 2023, an 11% increase year-over-year. The company launched the Proteograph XT Assay Kit and introduced the Seer Technology Access Center (STAC). They ended the quarter with $396 million in cash, cash equivalents and investments. The company expects full year 2023 revenue to be in the range of $16 million to $18 million.
- Achieved revenue of $4.0 million for the second quarter of 2023, an increase of 11% over the prior year period.
- Launched the Proteograph XT Assay Kit, enabling rapid proteomics across a range of sample types and species.
- Introduced the Seer Technology Access Center, providing mass spec services and end-to-end solutions.
- Expanded collaboration with Thermo Fisher Scientific to develop and optimize proteomics and proteogenomics workflows.
Headline financials
Revenue & EPS history
Seer · Revenue · Quarterly
$4.01M
Revenue by segment
Seer · $3.47M total across 3 segments · Q2 2023
- Product Revenue$1.65M-31.6%47.4%
- Related Party Revenue$1.36M+22.6%39.1%
- Service Revenue$467K+719.3%13.5%
Forward guidance
Seer now expects full year 2023 revenue to be in the range of $16 million to $18 million, representing growth of 10% at the mid-point of the range over full year 2022.
Historical earnings impact
How earnings announcements have historically affected this stock's price.
Avg. return before/after earnings
Based on 19 quarterly earnings reports · overlaid with Q2 2023
-1.1%
Avg return
Earnings day
-3.4%
Avg return
5 days after
-1.5%
Avg return
30 days after
38%
9 / 24 earnings
Positive
+39.4%
Q4 2022
Best reaction
-33.3%
Q2 2023
Worst reaction
| Quarter | Report date | Reaction (Day 0) | +5 days | +30 days |
|---|---|---|---|---|
| Q1 2026 | -2.7% | -7.7% | -6.0% | |
| Q4 2025 | -17.4% | -11.1% | -20.2% | |
| Q3 2025 | -1.4% | -4.6% | -13.4% | |
| Q1 2025 | +10.0% | +7.8% | +7.8% | |
| Q4 2024 | -4.5% | -7.3% | -20.9% | |
| Q3 2024 | +9.4% | +10.3% | +22.2% | |
| Q2 2024 | +0.0% | -1.2% | -4.7% | |
| Q1 2024 | -6.8% | -10.0% | -21.7% | |
| Q4 2023 | +1.1% | +6.1% | +5.6% | |
| Q3 2023 | -7.4% | -11.4% | -5.1% | |
| Q2 2023 | -33.3% | -40.6% | -43.6% | |
| Q1 2023 | -2.2% | -11.2% | +33.7% | |
| Q4 2022 | +39.4% | +20.8% | -1.3% | |
| Q3 2022 | -3.4% | +22.0% | -7.4% | |
| Q2 2022 | +19.5% | +6.9% | -12.4% | |
| Q1 2022 | +5.5% | -5.7% | +5.7% | |
| Q4 2021 | -6.6% | -15.3% | +1.8% | |
| Q3 2021 | -11.4% | -13.5% | -31.0% | |
| Q3 2020 | -11.4% | -13.5% | -31.0% | |
| Q2 2021 | +8.1% | -0.8% | +44.5% | |
| Q2 2020 | +8.1% | -0.8% | +44.5% | |
| Q1 2020 | -11.4% | -8.8% | +4.1% | |
| Q1 2021 | -16.1% | -22.2% | -17.9% | |
| Q4 2020 | +7.6% | +29.9% | +31.1% | |
| Q4 2019 | — | — | — |
Discussion
Share your read of this quarter. Sign-in carries your eToro identity.
Join the conversation
Sign in with eToro to post your read of this quarter and vote on others'.
Sign in with eToro